Please assess the completion status of the following clinical trial:

Trial Title: Surgical Weight Loss and Alcohol Perception

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Obese, with body weight less than 450 lbs~* non-smoking female volunteers of any race~* age 30-55 years~* drink alcohol in moderation and meet all of the BSC's indications and criteria for RYGB surgery. NIH/NIAAA criteria specify an average of between 3 and 7 standard drinks per week as moderate alcohol drinking (for women). In addition, included participants must fall within the upper or lower tercile of scores on the ASQ for a bariatric population, as determined by the investigator's previous studies with this population.9,10,19~Exclusion Criteria:~* their AUDIT scores (16 or above) indicate the possibility of a current or prior alcohol use disorder.~* they report typically drinking less than once per month and consuming less than 3-4 drinks per occasion.~* they are taking prescribed psychoactive medications, other than selective serotonin reuptake inhibitors (SSRIs) for anxiety/depression.~* they are taking medications that might interfere with alcohol metabolism (e.g., anti-histamine h2 receptor antagonists \[mainly, antacids used to treat GERD and gastro-intestinal ulcers\], certain antibiotics such as erythromycin, or other drugs influencing hepatic cytochrome P450 2E1; see medicine.iupui.edu/clinpharm/ddis/table.aspx).~* their medical records indicate current anemia.~* their FTND scores indicate moderate or greater nicotine dependence (4 or above).~* they report they are trying to become pregnant, or produce a positive urine screen for pregnancy at the lab session.~* their body weight is \> 450 lbs.~* they have participated in any other research study or medical procedure involving ionizing radiation exposure greater than a chest X-ray in the past 12 months.~* they live more than 60 miles from the CRC.

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Alcohol: Oral administration (Type: EXPERIMENTAL): Participants in this arm will consume a measured dose of alcohol orally, with the goal of achieving a target peak breath alcohol concentration of .065% within 20 minutes.
- Alcohol: Intravenous administration (Type: EXPERIMENTAL): Participants in this arm will be infused intravenously with a dose of alcohol sufficient to raise their breath alcohol concentration to .065% within 20 minutes.

Based on this trial design, predict the completion outcome and termination type (if applicable).